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depth some of the most pressing questions concerning the biology
of NSCs and BTSCs. We focus here on some of the key issues and
perspectives that emerged during the meeting.
NSC pathways, self-renewal and differentiation
When discussing NSCs, a first hurdle is always to agree on a
definition that encompasses the diverse nature of these cells, from
neuroblasts in Drosophila to radial glial cells and adult NSCs in the
mammalian brain. Formally, NSCs are defined as self-renewing
cells that can differentiate into any of the three major neural cell
lineages, namely neurons, astrocytes and oligodendrocytes (Temple
and Alvarez-Buylla, 1999). However, the inference that progenitor
cells of the nervous system have self-renewing capabilities arose
mainly through the use of in vitro assays, such as the neurosphere
assay (Reynolds and Weiss, 1992), and we are still missing formal
evidence that truly self-renewing cells are actually present in brain
tissues. For these reasons, we shall adopt here a more comprehensive
definition of NSCs, as proposed by Kriegstein and Alvarez-Buylla
(Kriegstein and Alvarez-Buylla, 2009), which defines NSCs as
being all ‘primary progenitor cells at different developmental stages
that initiate lineages leading to the formation of differentiated
neurons or glial cells’. This definition has the additional advantage
of exposing the pressing need to know in more detail the cellular
hierarchies that govern neural development, in particular in
vertebrates, and the molecular pathways regulating the successive
transitions that progenitors undergo along their path to
differentiation.
Role of FGF and retinoid signalling
Although in Drosophila we have abundant information on
neuroblast lineages, we know relatively little about the cellular
hierarchies that underlie vertebrate neural development. The first
vertebrate neural progenitors are found in the embryonic neural
plate, following neural induction, and their subsequent development
is known to be regulated by the interplay between fibroblast growth
factor (FGF) and retinoic acid (RA) signalling (Stavridis et al.,
2010). Kate Storey presented a detailed analysis of the transcriptome
alterations that occur in FGF-regulated neural progenitors in the
forming chick spinal cord, as they come under the influence of
retinoid signalling and commit to differentiation. Various molecules
that might control this transition have been identified by her group,
and of particular interest were the components of an alternative non-
canonical RA pathway that might promote proliferation, rather than
differentiation, in the neuroepithelium. Retinoids are also known to
control the onset of neuronal differentiation in the cortex
(Siegenthaler et al., 2009), and it will be interesting to compare
which branches of the RA pathway are at work in these two distinct
regions of the CNS.
The pro-differentiation effects of retinoids have been explored in
various clinical settings, particularly in the treatment of acute
promyelocytic leukaemias (Grimwade et al., 2009). Retinoids have
also been used for the treatment of neuroblastomas, and the
administration of 13-cis RA after chemotherapy is known to result
in longer patient survival. A better knowledge of retinoid signalling
might thus be important to target neuroblastomas more efficiently,
and Chris Redfern (University of Newcastle, UK) described his
work dissecting which retinoid receptors are involved in promoting
the differentiation of neuroblastoma cells. His laboratory has also
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Summary
The Company of Biologists recently launched a new series of
workshops aimed at bringing together scientists with different
backgrounds to discuss cutting edge research in emerging and
cross-disciplinary areas of biology. The first workshop was held
at Wilton Park, Sussex, UK, and the chosen theme was ‘Neural
Stem Cells in Development and Disease’, which is indeed a hot
topic, not only because of the potential use of neural stem cells
in cell replacement therapies to treat neurodegenerative
diseases, but also because alterations in their behaviour can, in
certain cases, lie at the origin of brain tumours and other
diseases.
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Introduction
In recent years, tumour cells with stem-like properties, called brain
tumour stem cells (BTSCs), have been isolated from various adult
and pediatric brain tumours, leading to the suggestion that cancer
growth might be fuelled by a small population of such cells (Dirks,
2008). Studies of these cells have revealed that they share certain
features with neural stem cells (NSCs), leading to the enticing
hypothesis that tumour-initiating cells in the brain arise from the
oncogenic transformation of endogenous NSCs, or from de-
differentiated committed neural progenitors or mature glial cells
(Dirks, 2008). If such BTSCs can be identified, they can be
specifically targeted in the treatment of brain tumours, an exciting
possibility with obvious clinical impact.
Given the proximity between NSCs and BTSCs, one of the goals
of this inaugural Company of Biologists Workshop, which was
organized by Kate Storey (University of Dundee, UK) and Silvia
Marino (Barts and The London School of Medicine, London, UK),
was to stimulate interactions between developmental biologists
and neuro-oncologists, in the hope that their cross-disciplinary
discussions and interactions could advance our understanding of the
biology of NSCs and the mechanisms involved in brain tumour
development. In the lovely setting of Wilton Park, in Sussex, UK,
surrounded by the beautiful English countryside and served with
excellent ‘gourmet’ food, there was ample opportunity to discuss in
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been searching for other signalling pathways that might interact with
retinoids, and he reported that inhibition of arachidonic acid
signalling sensitizes neuroblastoma cells to the pro-differentiation
effects of retinoids, a finding that might lead to better therapeutic
strategies.
Sox and Notch
Maintenance of vertebrate NSCs in the neural epithelium and their
controlled differentiation is regulated by a conserved genetic
network involving the Sox and proneural basic helix-loop-helix
(bHLH) transcription factors, together with the Notch pathway.
According to the current view, the SoxB1 family proteins Sox1-3
function to maintain NSC identity and to suppress differentiation,
while proneural bHLH proteins promote entry into differentiation
(Guillemot, 2007). The connections between the various
components of this circuitry are being actively studied, and Jonas
Muhr (Karolinska Institute, Stockholm, Sweden) described his
laboratory’s characterization of the genetic programmes elicited by
different SoxB1 proteins in NSCs and how they interact with other
Sox proteins, such as Sox4 and Sox11, to regulate progenitor
maintenance or differentiation. The interplay between SoxB1 and
proneural bHLH proteins seems also to be crucial in this decision,
as entry into differentiation requires the absence of SoxB1 activity.
It is therefore not surprising that a SoxB1 gene, Sox2, has been
implicated in the generation of gliomas, being essential to sustain
their stem-cell-like potential downstream of TGF signalling
(Ikushima et al., 2009), in what constitutes another striking example
of the molecular analogies between NSCs and BTSCs. An exception
to the normal role of proneural bHLH factors in promoting NSC
differentiation was described by François Guillemot (National
Institute for Medical Research, London, UK), who showed that the
proneural gene Ascl1 is transiently expressed, and maintains NSCs,
in the adult subependymal zone (SEZ) and the subgranular zone
(SGZ) in the adult dentate gyrus, probably by coordinating the
transcriptional activation of various genes encoding positive
regulators of the cell cycle. However, deletion of Ascl1 does not
seem to cause a similar loss of NSC proliferation in the embryonic
telencephalon, suggesting that NSCs in the embryonic and adult
brain may be maintained by distinct genetic circuitries. It will thus
be interesting to investigate whether Ascl1 expression is part of a
genetic signature that is specific to BTSCs arising from the adult
brain.
Notch signalling is also a well-established player in the molecular
pathways regulating NSC maintenance, both in the embryo and
during adult neurogenesis (Louvi and Artavanis-Tsakonas, 2006).
Removal of Notch activity in cultures of NSCs derived from
embryonic stem (ES) cells leads to their premature differentiation,
and Domingos Henrique (Instituto Medicina Molecular, Lisbon,
Portugal) reported the characterization of the Notch synexpression
group active in these NSCs, through extensive transcriptome
analysis. Various novel Notch targets have been identified in this
analysis, and the challenge is to define which components of the
pathway are active in NSCs and contribute to BTSC maintenance.
An interesting twist on the canonical view that Notch signalling
serves to maintain proliferating NSCs in the CNS was provided by
Laure Bally-Cuif (Institute of Neurobiology, Gif-sur-Yvette,
France), whose laboratory obtained evidence that Notch is active in
quiescent NSCs of the zebrafish adult brain and regulates the
transition of these cells to a proliferative state, prior to neurogenesis.
Similar data were recently obtained in the adult mouse SEZ,
pointing to the likely conservation of this mechanism (Imayoshi et
al., 2010). Drosophila neuroblasts also become quiescent in the
period between embryonic and larval neurogenesis, and it will be
interesting to identify conserved components of the Notch pathway
that specifically mediate this pro-quiescent function in NSCs. Notch
is part of a specific ‘niche’ that sustains adult neurogenesis in the
SEZ, and Fiona Doetsch (Columbia University, NY, USA) discussed
other aspects of this niche, in particular the vascular component,
presenting a general view of the cellular architecture that underlies
homeostatic neuronal production at the SEZ (Fig. 1) (Tavazoie et al.,
2008). Despite an apparently uniform niche, there is significant
heterogeneity in the adult NSC population, concerning their
potential to generate different subtypes of neurons, a finding that
poses a problem for defining a common NSC molecular signature
that allows an unequivocal identification of these cells in the adult
brain. To address the contribution of intrinsic mechanisms in
generating this heterogeneity, Magdalena Götz’s laboratory
(Institute of Stem Cell Research, Munich, Germany) developed a
method to culture NSCs from the adult SEZ at the clonal level,
without added growth factors, in which the lineages generated by
each isolated NSC can be traced. Using this approach with live
imaging, her laboratory could show for the first time that adult NSC
asymmetric divisions generate transit-amplifying progenitors while
self-renewing. As predicted from in vivo data (Brill et al., 2009),















A B Fig. 1. Model of the SEZ cellular architecture in
the adult mouse brain. (A)Cross section of an
adult mouse brain at the level of the subependymal
zone (SEZ) of the lateral ventricle. Dorsal is
uppermost. CC, corpus callosum. (B)High
magnification of the SEZ area boxed in A.
Ependymal cells (black) line the lateral ventricle.
Neural stem cells (NSCs) correspond to type B
astrocytes (B cell, blue) and possess an apical
process that extends into the ventricle, while their
basal end contacts blood vessels. NSCs generate
transit-amplifying progenitors (TAPs) that divide
and generate neurons. NSCs also generate
oligodendrocyte progenitors (OPCs) that give rise to
mature oligodendrocytes. The architecture of the
SEZ is drawn from the results presented in
Mirzadeh et al. (Mirzadeh et al., 2008) and
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most of the progeny in this culture system are neuronal and
predominantly GABAergic. The recently discovered glutamatergic
neuron lineage is also preserved in this system. Full transcriptome
analysis of NSCs isolated from the SEZ without culturing showed
that these cells are enriched for the expression of various neuronal-
specific transcription factors, such as Sox4, Sox11, Dlx1, Ascl1 and
Pax6, suggesting that adult SEZ NSCs are intrinsically primed to
neuronal differentiation. The finding that ectopically transplanted
SEZ NSCs do not produce neurons (Seidenfaden et al., 2006) is
therefore likely to be due to the existence of restrictive environments
that repress neuronal differentiation in most brain regions. These
environmental restrictions also seem to influence oligodendrocyte
maturation, as suggested by David Rowitch (University of
California, San Francisco, CA, USA), who identified Wnt signalling
as a restrictive factor that opposes the progression of Olig2-positive
oligodendrocyte progenitors (OLPs) into myelin-generating
oligodendrocytes. These ‘blocked’ OLPs are found in multiple
sclerosis lesions and in periventricular leukomalacia, an ischemic
brain injury in premature infants, indicating that these diseases are
due to an inhibition of OLP differentiation (Fancy et al., 2009).
These findings hint at the exciting possibility of targeting Wnt
signalling to remove the blockade of OLP differentiation, a
therapeutic approach that might lead to better clinical outcomes in
these devastating diseases.
Asymmetric division and NSC self-renewal
Asymmetric division is a key mechanism that ensures stem cell self-
renewal, but also tissue growth and homeostasis. Studies in
Drosophila have been successful in unravelling the intrinsic
mechanisms that regulate neuroblast asymmetric division in the
embryonic and larval neuroepithelium (Chia et al., 2008). At
mitosis, neuroblasts establish an apicobasal polarity, with two
protein complexes (the PAR and the PINS complex) localizing
apically and causing the basal segregation of certain polarity
proteins, including the adaptor protein Miranda (Mira), the PTB-
domain protein Numb, the translational repressor Brat and the
homeodomain transcription factor Prospero (Pros). Upon neuroblast
cytokinesis, and following the alignment of the spindle along the
apicobasal axis, the apical and basal proteins are inherited differently
by the two daughter cells, which then acquire different fates: the
apical cell remains a neuroblast, while the basal cell becomes a
ganglion mother cell (GMC) and undergoes terminal division before
differentiation. When spindle orientation is irregular and partitioning
of the apical and basal proteins abnormal, the ratio of apical versus
basal activities inherited by each daughter cell determines their fate,
as shown by Chris Doe’s laboratory (University of Oregon, Eugene,
USA) in their analysis of mud mutants. mud encodes a coiled-coil
protein that links the spindle microtubules to the apical PINS
complex and in its absence spindle orientation is not perfectly
aligned with the neuroblast apicobasal axis. Live imaging of
dividing mud mutant cells, induced by the MARCM technique (Wu
and Luo, 2006), revealed that in cases in which the spindle becomes
orthogonal, both daughter cells follow a neuroblast fate, irrespective
of having also inherited basal components (Cabernard and Doe,
2009). This implies that the apical machinery is able to impose a
neuroblast fate even when normal amounts of basal components are
present, but little is known about how this machinery functions to
promote the neuroblast fate. Nonetheless, unusually high levels of
Pros can still impose a basal GMC fate even in the presence of apical
complexes, in part by targeting cell cycle genes such as cyclins (A
and E) and string (cdc25). Andrea Brand (Gurdon Institute,
University of Cambridge, UK) reported that among the direct targets
of Pros in the Drosophila embryonic CNS are genes like asense,
deadpan and snail, which promote self-renewal and multipotency
and are downregulated by Pros in GMCs. Strikingly, the
transcription factors Asense, Deadpan and Snail bind to a very
similar set of targets to Pros. However, whereas Pros represses
neuroblast-related genes and activates differentiation genes, the
other three factors have the opposite activities (Southall and Brand,
2009). Combined with expression profiling, such results are a step
towards building the gene regulatory networks that govern the
decision between self-renewal and differentiation in the neuroblast
hierarchy.
These findings are also relevant to studies of NSCs in the
vertebrate neuroepithelium, in which asymmetric divisions
following a precise spindle orientation are also proposed to control
cell fate and the timing of neurogenesis (Götz and Huttner, 2005).
Charles ffrench-Constant (University of Edinburgh, UK) proposed
that integrins participate in the spindle orientation machinery in
mouse embryonic cortical NSCs. In a provocative set of
experiments, he showed that in utero injection of integrin-blocking
antibodies into the brain ventricle of E14-E15 mouse embryos led
(among other phenotypes) to changes in the angle of progenitor cell
divisions, which became more vertical. Because such divisions
might lead to the asymmetric partitioning of the junctional
components, these results raise the possibility that integrin signalling
may control the transition from symmetrical to asymmetrical
divisions in the mouse embryonic cortex.
In search of the tumour-initiating cell
Many brain tumour types can develop in humans, differing in their
time of onset, the differentiated cell type involved (astrocytic,
oligodendrocytic, immature), and their location (supra- or infra-
tentorial, or spinal). This heterogeneity indicates that brain
tumours have distinct cellular and molecular initiation
mechanisms, raising several questions concerning the origin of the
tumour-initiating cell and the molecular alterations that cause the
emergence and progression of brain tumours. Drosophila offers an
excellent model with which to address such questions, as
malignant tumours can be conditionally induced in the larval
nervous system during neurogenesis, and because direct imaging
of cellular behaviour is feasible in ‘open brain’ preparations. Using
this system, at least three distinct modes of tumour initiation from
stem or progenitor cells have been recognized (Januschke and
Gonzalez, 2008) and were further illustrated at the meeting
(Fig. 2A). In the first mode, the neuroblast fails to divide
asymmetrically, as in the mud mutants reported by Chris Doe, and
the two daughter cells inherit both apical and basal activities,
behaving as neuroblasts and continuing to divide symmetrically to
expand the neuroblast pool. However, normal neuroblasts do not
expand uncontrollably, nor do they generate tumours after
transplantation. So, what further alterations are needed to cause
the uncontrollable proliferation of symmetrically dividing
neuroblasts? A clue came from Chris Doe, who reported a novel
mutant in which the formation of the apical PAR complex is
defective. Neuroblasts from this mutant only become tumourigenic
when they additionally lose PINS, unveiling a combination of
events that contributes to neuroblast transformation.
A second mechanism that might lead to the generation of tumours
within the Drosophila larval brain lobes involves a fate reversal from
a GMC to a stem-like neuroblast state. Such reversions arise due to
mutations in components of the basal machinery that promote GMC
commitment and repression of self-renewal, like pros, mira and lgl











errors in differentiation can lead to cancer (Harris, 2005): mutant
cells are unable to implement the differentiated phenotype and
proliferate abnormally, causing tumour formation.
In the third mode of tumour formation, the tumour-initiating cell
seems to be a progenitor cell in the type II neuroblast lineage, a
newly described set of neuroblasts that develop through a ‘transit-
amplifying’ phase of intermediate, asymmetrically dividing
progenitors (Fig. 2A) (Bello et al., 2008; Boone and Doe, 2008).
These progenitors show apicobasal polarity and self-renew like a
neuroblast, dividing asymmetrically to produce another progenitor
and a GMC. Their intrinsic self-renewal capacity seems to make this
lineage particularly susceptible to mutations in genes promoting
commitment to differentiation, as is the case for mutations in brat
and numb, which cause the developmental arrest of the progenitors
in the self-renewal state and lead to their unrestrained proliferation
(Bowman et al., 2008). This susceptibility was explored by Jurgen
Knoblich (Institute of Molecular Biotechnology, Vienna, Austria) in
a large-scale RNA interference (RNAi) screen aimed at identifying
new tumourigenic loci that cause abnormal type II neuroblast
proliferation. Several new mutants have been identified that might
help to elucidate the molecular pathways that underlie neuroblast
and progenitor self-renewal, and how alterations in these pathways
can lead to tumour formation.
Comparable studies in mammalian systems are in progress that
aim to elucidate which cells are competent to initiate tumour
development and the molecular lesions involved (Fig. 2B). In a
direct test of the hypothesis that oncogenic insults to NSCs might
transform these cells into BTSCs, Sebastian Brandner [University
College London (UCL), UK] reported on how mutations in known
tumour suppressor genes, such as the retinoblastoma (Rb) gene,
p53 and Pten, were tested for their capacity to transform NSCs in
the mouse. All tested combinations (deletions in NSCs of Rb
and p53, of p53 and Pten, or of all three genes) proved to be
tumourigenic, leading to the formation of primitive
neuroectodermal tumours (in the case of Rb;p53 or Rb;p53;Pten
deletion) or gliomas (for the p53;Pten deletion). To exclude that
transformed astrocytes contribute to these tumours, the same
deletions were introduced into mature astrocytes, with no observed
malignancy. Hence, it appears that NSCs in the SEZ are
susceptible to human cancer-causing mutations. There are other
examples of NSC-derived brain tumours, such as the Hedgehog-
dependent medulloblastomas that originate from cerebellar
granule cell precursors (Fults, 2005), and Richard Gilbertson (St
Jude Children’s Research Hospital, Memphis, USA) described a
new subgroup of human medulloblastomas characterized by
mutations in the -catenin gene (CTNNB1). He further showed
that targeted expression of mutant (activated) -catenin in the
mouse embryonic hindbrain led to stalled cell migration and to
hyperplasia, followed by medulloblastoma development in a
manner very reminiscent to that of the human tumour. However,
the fact that embryonic and adult NSCs can drive tumour growth
does not mean that NSCs do so in the majority of cases in real life,































Fig. 2. A model of tumourigenic events in the Drosophila neuroblast and the mammalian neural stem cell lineages. (A)In Drosophila,
neuroblasts (NBs) serve as stem cells and divide asymmetrically. The daughter cell that inherits apical determinants (blue) self-renews, while the
daughter that inherits the basal components (brown) commits to neurogenesis following the nuclear localization of Prospero (pink). Neuroblasts of
(a) type I and (b) type II differ in the absence or presence, respectively, of a transit-amplifying progenitor (TAP), which itself divides asymmetrically to
self-renew and generate a ganglion mother cell (GMC). The different steps at which tumour initiation can occur (see text) are indicated by arrows,
as are the affected cell-fate decisions. (B)A theoretical lineage for mammalian brain NSCs, based on the established mammalian SEZ paradigm. A
self-renewing NSC (S) gives rise to TAPs that then generate neurons. By analogy with Drosophila, the steps at which cell fate can go awry with
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and major questions remain as to the origin of most types of brain
tumours, including many forms of glioma (in particular those of
late onset, when NSCs are scarce) and ependymomas. Most
interestingly, as shown by the same group (Zhu et al., 2008),
activation of Wnt signalling in cells expressing the NSC marker
prominin (CD133) did not lead to neoplastic transformation in the
mouse brain, indicating that Wnt activation in adult NSCs is not
sufficient to drive tumour transformation. In line with these
findings, Silvia Marino reported that when the expression of Bmi1,
which encodes a polycomb group (PcG) protein known to regulate
NSC self-renewal, is upregulated in the embryonic telencephalon,
no brain tumours were formed, although the self-renewal potential
of these cells is enhanced. It may therefore be possible to develop
strategies to increase a NSC pool to enhance regeneration without
triggering brain tumour formation.
More generally, understanding what makes a tumourigenic
progenitor cell different to a normal progenitor cell is a crucial issue,
and active efforts are underway to quantitatively and molecularly
phenotype brain tumours. An extensive transcriptome analysis of
human ependymomas by the Gilbertson laboratory, for example, has
allowed them to classify these tumours into nine distinct subgroups.
The profile of each subgroup reveals a regional signature (e.g.
forebrain, spinal) that contains a particular set of overexpressed
oncogenes. Most interestingly, the overexpression of site-specific
oncogenes in appropriately matched neural progenitors recapitulated
the development of ependymomas. The in-depth analysis of the
functional interactions between the regional identity markers and
oncogenes found in each tumour subtype will provide unique insight
into the differential sensitivity of progenitor cells to tumourigenic
transformation and the mechanisms involved. Such analyses in
humans, however, are generally conducted long after a tumour has
arisen, leaving time for extensive molecular changes to take place in
cancerous cells. By taking advantage of the ability to induce the
initial tumourigenic event in a timed manner in Drosophila,
Cayetano Gonzalez (Institute for Research in Biomedicine,
Barcelona, Spain) has analysed the early molecular signature of
various induced tumours and has identified unique genetic
programmes that are ectopically activated during the initial phases
of tumour development and functionally required for tumour
growth.
Towards identifying the epigenetic (versus genetic) alterations
that might be associated with stem cell tumourigenicity, Steve
Pollard (UCL, London, UK) focused on several human-derived
glioblastoma NSC (GNS) lines that display different molecular
signatures while all retaining tumour-initiating potential (Pollard
et al., 2009). By challenging these cells through the forced
expression of the pluripotency factors OCT4 and KLF4, he found
that around one fifth of the GNS lines could be reprogrammed to
the iPS (induced pluripotent stem) state. A comparison of the
epigenetic status of the derived iPS lines with normal NSCs and
the original GNS cells should now allow for the identification
of epigenetic modifications associated with tumourigenic
potential.
Such detailed information on NSC biology is of considerable
therapeutic value. A recently characterized example, pointed out by
Michael Weller (University Hospital Zurich, Switzerland), is the use
of alkylating agent chemotherapy in the treatment of glioblastoma
that is characterized by the methylation of the MGMT gene.
MGMT (the DNA repair enzyme O-6-methylguanine-DNA-
methyltransferase) antagonizes the genotoxic effects of alkylating
agents, and epigenetic MGMT gene silencing in tumours is of good
prognostic value for such treatments (Weller et al., 2010). A
recurring finding at the meeting, however, was that there is an
unforeseen variety of glioma (and other brain tumour) subtypes and,
within each subtype, of molecular markers. Along these lines,
Michael Weller reported on efforts to establish databases of patients
with the aim of matching such molecular information and specific
prognostic or predictive signatures, to help with selecting the best
possible treatment option.
Conclusions
Advances in our knowledge of brain development are revealing
surprising nuances in the molecular and functional features of NSCs,
from Drosophila neuroblasts to glial progenitors in the adult
mammalian brain. This NSC heterogeneity underlies the large
cellular diversity of the nervous system, and much effort is being
focused on dissecting the regionalization mechanisms that
contribute to the establishment of specific NSC hierarchies in
different brain regions. Genome-wide comparisons of the
transcriptional and epigenetic signatures of different NSCs, at
various steps of their progression to differentiation, are helping to
build a detailed molecular roadmap of NSC specification. Similar
analyses are also underway in several types and subtypes of brain
tumours, in humans and in Drosophila, which will lead to a better
definition of the molecular pathways recruited by tumour-initiating
cells to promote malignant growth. This analysis, coupled with
increasingly powerful functional studies in Drosophila and in mice,
will lead to significant progress in our understanding of brain
development and of how brain tumours can be treated with patient-
specific therapeutic approaches.
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